Steven M. Fruchtman
Overview
Steven M. Fruchtman received an average of $1M in total compensation, including $521K in salary, at Onconova Therapeutics from 2015 to 2023.
2023Onconova TherapeuticsPresident and Chief Executive Officer
2022Onconova TherapeuticsPresident and Chief Executive Officer
2021Onconova TherapeuticsPresident and Chief Executive Officer
2020Onconova TherapeuticsPresident and Chief Executive Officer
2018Onconova TherapeuticsPresident and Chief Medical Officer
2017Onconova TherapeuticsChief Medical Officer and Senior Vice President, Research and Development
2016Onconova TherapeuticsChief Medical Officer and Senior Vice President, Research and Development
2015Onconova TherapeuticsChief Medical Officer and Senior Vice President, Research and Development
Source: SEC filings on October 11, 2024, June 7, 2023, May 25, 2022, April 29, 2019, June 8, 2018, and April 12, 2017.
Related executives
We found seven more executives who work or worked at Onconova Therapeutics.
Mark Guerin
Onconova Therapeutics
Chief Financial Officer
Victor Moyo
Onconova Therapeutics
Chief Medical Officer
Mark Gelder
Onconova Therapeutics
Chief Medical Officer
Abraham Oler
Onconova Therapeutics
General Counsel
Ramesh Kumar
Onconova Therapeutics
Chief Executive Officer
Manoj Maniar
Onconova Therapeutics
Senior Vice President, Product Development
Thomas McKearn
Onconova Therapeutics
President of Research and Development
News
Onconova Therapeutics CEO Steven Fruchtman's 2023 pay slips 17% to $1.1M
October 11, 2024
Onconova Therapeutics CEO Steven Fruchtman's 2022 pay falls 50% to $1.3M
June 7, 2023
Onconova Therapeutics CEO Steven Fruchtman's 2021 pay jumps 159% to $2.7M
May 25, 2022
Onconova Therapeutics CEO Ramesh Kumar's 2018 pay jumps 82% to $1.2M
April 29, 2019